Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...
But in announcing the cuts, 23andMe CEO Anne Wojcicki said her goal is to ensure the "long-term success" of its core consumer ...
In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback